Research Article
Oncologic Outcomes of Renal Cell Carcinoma Patients Undergoing Radical Nephrectomy and Venous Thrombectomy: Prospective Follow-Up from a Single Center
Table 2
Surgical and pathological outcomes of the study cohort.
| Characteristics | Value |
| Type of surgery | | Laparoscopic surgery | 130 (48.1) | Open surgery | 140 (51.9) | Adrenalectomy (/%) | 123 (45.6) | Segmental resection of IVC (/%) | 45 (16.7) | Resection of metastatic tumor (/%) | 4 (1.5) | Operative time (min), median (IQR) | 320 (240-404) | Blood loss (ml), median (IQR) | 700 (200-1800) | Blood transfusion (/%) 1133llchmu109f | 136 (50.4) | Packed RBC transfusion (ml), median (IQR) | 1200 (800-2000) | FFP transfusion (ml), median (IQR) | 600 (400-800) | Postoperative SCR | 98 (79-116) | Complications (/%) | 88 (32.6) | Cardiovascular or cerebrovascular events | 2 (0.7) | Pneumonia or pleural effusion | 10 (3.7) | Kidney insufficiency | 10 (3.7) | Abdominal cavity infection | 4 (1.5) | Incision infection | 2 (0.7) | Deep venous thrombus | 23 (8.5) | Anemia | 22 (8.1) | Bowel obstruction | 16 (5.9) | Lymphatic fistula | 9 (3.3) | Death | 4 (1.5) | Clavien grade of complications (/%) | | I | 6 (2.2) | II | 51 (18.9) | III | 0 | IV | 11 (4.1) | V | 4 (1.5) | Postoperative hospital stay (d), median (IQR) | 9 (6-12) | Histology (/%) | | Clear cell RCC | 225 (83.3) | Papillary type RCC | 30 (11.1) | Chromophobe RCC | 2 (0.7) | Unclassified RCC | 7 (2.6) | Squamous RCC | 1 (0.4) | TFE-3 translocation RCC | 5 (1.9) | T stage | | pT3a | 50 (8.5) | pT3b | 124 (45.9) | pT3c | 80 (29.6) | pT4 | 16 (5.9) | Lymph node metastasis | 93 (34.4) | Perinephric fat invasion | 73 (27.0) | Involving the venous wall (/%) | 58 (21.5) | Sarcomatoid differentiation | 30 (11.1) | Fuhrman grade (/%) | | 1 | 5 (1.8) | 2 | 98 (36.3) | 3 | 113 (41.9) | 4 | 54 (20.0) | Adjuvant therapy | 155 (57.4%) |
|
|
RCC: renal cell carcinoma; IVT: inferior vena cava; RBC: red blood cells; FFP: fresh frozen plasma; ASA: American Society of Anesthesiologists; IQR: interquartile range; SCR: serum creatinine.
|